SRF Limited has announced the approval of a new pharmaceutical intermediates manufacturing plant in Dahej, Gujarat, marking a significant expansion in the company's manufacturing capabilities. The project involves a total investment of ₹180.00 crores and represents SRF's strategic entry into the pharmaceutical intermediates sector.

Investment Details

The company's board has approved the establishment of this new facility with the following key parameters:

Strategic Expansion

The Dahej pharmaceutical intermediates plant represents SRF's diversification strategy beyond its traditional chemical and specialty products business. Pharmaceutical intermediates are essential components in the pharmaceutical supply chain, serving as building blocks for active pharmaceutical ingredients and finished drug products. This expansion positions SRF to capitalize on the growing demand in the pharmaceutical sector.

Facility Location

Dahej, located in Gujarat, is a well-established industrial hub with excellent infrastructure and connectivity. The location offers strategic advantages including proximity to ports for raw material imports and finished product exports, along with access to skilled workforce and industrial support services. The facility will add to SRF's existing manufacturing footprint across multiple locations.

Business Impact

This investment demonstrates SRF's commitment to expanding its product portfolio and entering high-growth sectors. The pharmaceutical intermediates business typically offers stable demand patterns and attractive margins, providing the company with additional revenue streams and reduced dependence on traditional chemical products. The new facility will enhance SRF's manufacturing capabilities and strengthen its position in the specialty chemicals ecosystem.

SRF Limited has announced its second interim dividend for the financial year 2025-26, demonstrating the company's commitment to returning value to shareholders. The Board of Directors approved this dividend declaration at their meeting held on January 20, 2026.

Dividend Details

The company has declared an interim dividend at the rate of 50%, translating to ₹5.00 per share on the paid-up equity share capital. This represents the second interim dividend payment for the current financial year.

Eligibility and Payment Schedule

Shareholders will be eligible for the interim dividend based on their holdings as recorded on the specified record date. The dividend will be paid to members whose names appear on the Register of Members and beneficial owners as per details received from National Securities Depository Limited and Central Depository Services (India) Limited, as on Tuesday, January 27, 2026.

The company has committed to disbursing the interim dividend payment on or before Tuesday, February 17, 2026, ensuring timely distribution to eligible shareholders.

Corporate Communication

The dividend declaration was formally communicated to both BSE Limited and National Stock Exchange of India Limited through official correspondence dated January 20, 2026. The announcement was signed by Rajat Lakhapal, Senior Vice President (Corporate Compliance) and Company Secretary, maintaining proper corporate governance protocols.

This second interim dividend payment reflects SRF Limited's financial performance and its strategy to provide regular returns to shareholders during the ongoing financial year.